Abstract: Disclosed are T-cell receptors (TCRs) binding to tumor-associated antigens (TAAs) for targeting cancer cells, T-cells expressing same, methods for producing same, and methods for treating cancers using same. Disclosed are TCRs and their variants that bind to HLA class I or II molecules with a peptide, such as MAG-003 have the amino acid sequence of KVLEHVVRV (SEQ ID NO:1). The description further relates to peptides, proteins, nucleic acids, cells for use in immunotherapeutic methods, the immunotherapy of cancer, and tumor-associated T-cell peptide epitopes, alone or in combination with other tumor-associated peptides that can for example serve as active pharmaceutical ingredients of vaccine compositions that stimulate anti-tumor immune responses, or to stimulate T-cells ex vivo and transfer into patients. Peptides bound to molecules of the major histocompatibility complex (MHC), or peptides as such, can also be targets of antibodies, soluble T-cell receptors, and other binding molecules.

Abstract: The present disclosure provides compositions and methods for targeting a minor histocompatibility (H) antigen (HA-1H) to, for example, prevent or manage relapse of a hematological malignancy after allogeneic hematopoietic stem cell transplantation (HCT). Also provided are transgene constructs encoding engineered binding proteins, such as a T cell receptor or a chimeric antigen receptor, optionally encoding additional components such as a co-receptor and/or safety switch. Such transgene constructs can be transduced into an immune cell, such as a T cell, and used as an immunotherapy in a subject having a hematological malignancy or at risk for recurrence of the hematological malignancy (e.g., leukemia, lymphoma, myeloma).

Abstract: There are described herein novel soluble IGF receptor Fc fusion proteins and compositions and methods of use thereof for treating angiogenesis associated disorders and malignant disease, such as cancer and metastasis, wherein the fusion proteins bind specifically to IGF-1 or IGF-2.

Abstract: The invention is related to the production and development of a lyophilized injectable formulation of modified antibodies or their variants, highly specific neutralizers of heterologous mixtures of proteins, peptides and other organic or inorganic components have different specific activities and may include but are not limited to the venoms of venomous animals. For convenience, we refer to venoms, but all type of venoms was included of land and marine animals. It is also addressed to the production method which includes the hyperimmunization of mammals for the production of highly specific antibodies, the modification (fragmentation) and purification process, and finally the injectable formulation conferring thereon properties of high purity and high specificity.

Abstract: The present invention provides antibodies (e.g., monoclonal antibodies, human antibodies, humanized antibodies, etc.), which bind to multiple influenza strains. Such antibodies are useful, for example, in the prophylaxis, treatment, diagnosis, and/or study of influenza.

Abstract: The present invention relates, in part, to bispecific antibodies that bind the pertussis toxin protein. The present invention further relates to the use of the bispecific antibodies for the prevention and treatment of Bordetella pertussis infections.

Abstract: An anti-equol antibody composition, containing an anti-equol antibody or antibody fragment thereof containing, as an immunoglobulin heavy chain variable region, hypervariable regions CDR1, CDR2, and CDR3 respectively including amino acid sequences represented by SEQ ID NO: 1-3, and as an immunoglobulin light chain variable region, hypervariable regions CDR1?, CDR2?, and CDR3? respectively including amino acid sequences represented by SEQ ID NO: 4-6; and an anti-equol antibody or antibody fragment thereof containing, as an immunoglobulin heavy chain variable region, hypervariable regions CDR1, CDR2, and CDR3 respectively including amino acid sequences represented by SEQ ID NO: 1-3, and as an immunoglobulin light chain variable region, hypervariable regions CDR1?, CDR2?, and CDR3? respectively including amino acid sequences represented by SEQ ID NO: 7-9.

Abstract: Anti-A? globulomer antibodies, antigen-binding moieties thereof, corresponding hybridomas, nucleic acids, vectors, host cells, methods of producing said antibodies, compositions comprising said antibodies, uses of said antibodies and methods of using said antibodies. The present invention relates to anti-A? globulomer antibodies having a binding affinity to A?(20-42) globulomer that is greater than the binding affinity of the antibody to A?(1-42) globulomer, antigen-binding moieties thereof, hybridomas producing said antibodies, nucleic acids encoding said antibodies, vectors comprising said nucleic acids, host cells comprising said vectors, methods of producing said antibodies, compositions comprising said antibodies, therapeutic and diagnostic uses of said antibodies and corresponding methods relating to Alzheimer's disease and other amyloidoses.

Abstract: The present invention relates to variable domains of a camelid heavy-chain antibodies directed against a phosphorylated tau protein and conjugates thereof. The present invention also relates to the use of these domains or conjugates for treating or diagnosing disorders mediated by neurofibrillary tangles, neuropil threads or dystrophic neurites, such as tauopathies.

Abstract: The instant disclosure provides antibodies that specifically bind to ApoC3 (e.g., human ApoC3) and antagonize ApoC3 function. Also provided are pharmaceutical compositions comprising these antibodies, nucleic acids encoding these antibodies, expression vectors and host cells for making these antibodies, and methods of treating a subject using these antibodies.

Abstract: The invention provides a method of enhancing bone gap defect healing involving administering a sclerostin inhibitor.

Abstract: Herein are reported anti-ANG2 antibodies. A specific anti-ANG2 antibody comprises (a) a HVR-H1 comprising the amino acid sequence of SEQ ID NO: 20, (b) a HVR-H2 comprising the amino acid sequence of SEQ ID NO: 21, and (c) a HVR-H3 comprising the amino acid sequence of SEQ ID NO: 23.

Abstract: The present disclosure is directed to the treatment of diseases or conditions involving the buildup of fatty tissues, such as obesity, metabolic syndrome, type II diabetes, etc. A composition containing a monoclonal antibody directed against gastric inhibitory polypeptide is administered. This results in a reduced rate of weight gain and a marked decrease in lipid synthesis and accumulation.

Abstract: The present disclosure relates to antibodies or fragments thereof that target at least one conformational epitope of a Notch 3 or mutant Notch 3 receptor; and compositions and methods of use thereof.

Abstract: The presently disclosed subject matter provides for methods and compositions for enhancing the immune response toward cancers and pathogens. It relates to chimeric antigen receptors (CARs) that specifically target human mesothelin, and immunoresponsive cells comprising such CARs. The presently disclosed mesothelin-targeted CARs have enhanced immune-activating properties, including anti-tumor activity.

Abstract: Provided herein are methods and compositions for treating a subject suffering from an enzyme deficiency in the central nervous system (CNS). The bifunctional fusion antibody provided herein comprise an antibody to an endogenous blood brain barrier (BBB) receptor and an enzyme deficient in mucopolysaccharidosis IIIB (MPS-IIIB). The fusion antibodies provided herein comprise alpha-N-acetylgulcosaminidase (NAGLU). The methods of treating an enzyme deficiency in the CNS comprise systemic administration of a fusion antibody provided herein.

Abstract: The present disclosure relates to compositions and methods of killing cells in vitro or in vivo. In particular examples, the method includes contacting a cell having a cell surface protein with a therapeutically effective amount of an antibody-IR700 molecule, wherein the antibody specifically binds to the cell surface protein. In particular examples the antibody recognizes a tumor-specific antigen on the surface of a tumor cell. The cell is subsequently irradiated, such as at a wavelength of 660 to 740 nm at a dose of at least 1 J cm?2, thereby killing the cell. Also provided are wearable devices that include an article of clothing, jewelry, or covering; and an NIR LED incorporated into the article, which can be used with the disclosed methods.

Abstract: Embodiments described herein provide anti-fibulin-3 antibodies, recombinant proteins that bind specifically to fibulin-3, compositions and the treatment methods comprising these antibodies and recombinant proteins.

Abstract: The present disclosure relates to anti-SSEA4 antibodies and bindings fragments thereof comprising specific complementarity determining regions capable of high affinity binding to SSEA4 molecules and SSEA4-associated expressing tumor cells, such as breast cancer, pancreatic cancer, and renal cancer cells. The anti-SSEA4 antibodies and binding fragments induce ADCC or CDC effects in the targeted tumor cells and inhibit and/or reduce the cancer/tumor proliferation. The present disclosure also provides anti-SSEA4 antibodies and binding fragments thereof as a pharmaceutical composition for treating cancer. In addition, the anti-SSEA4 antibodies and binding fragments are useful in the diagnosis of cancers.

Abstract: There are many reports of diseases caused by overeating, satiation, and an unbalanced diet, and various therapeutic methods and therapeutic drugs are proposed for said diseases. There have not been many proposals, for prevention of these diseases, of methods by which what is eaten is not readily absorbed in vivo. The present invention involves inoculating female birds with a digestive enzyme as an antigen, said digestive enzyme being present in vivo. As a result of inhibiting the activity of the digestive enzyme by using an antibody which has been produced in vivo in the birds, the present invention inhibits decomposition of proteins, lipids, and carbohydrates and reduces in vivo absorption. This type of antibody can be obtained from an egg laid by a female bird which has received the antigen, and furthermore the egg itself includes the antibody. Consequently, a food product that contains, as an ingredient thereof, eggs having this type of antibody is low in proteins, lipids, and carbohydrates.

Abstract: Provided herein are methods and compositions for analyzing epigenetic modifications of genomes. The methods and compositions are suited for complete epigenome sequencing of any modification for which an antibody or an affinity binding agent has been developed. In one aspect, provided herein is a method for analyzing epigenetic modification of a genome. In some embodiments of aspects provided herein, the method further comprises sequencing a sequencing library to generate sequence reads, and assembling the sequence reads with aid of a positional barcode sequence information. In some embodiments of aspects provided herein, the method further comprises determining a location of at least two different epigenetic modifications of the nucleic acid. Another aspect of the present disclosure provides a kit for analyzing an epigenetic modification of a nucleic acid.

Abstract: Novel multispecific antibody platform, multispecific antibodies and a method to make the antibodies is disclosed here. The CH3 domain harboring polypeptide chains of the Fc-regions are modified by increasing the positive charge of one chain and negative charge of another chain. Heterodimer formation in cotransfection with the modified chains is comparable to formation of wild type antibodies when same cell line is transfected with wild type polypeptides. Moreover, the modification provides a simple one step purification of the heterodimers.

Abstract: The present disclosure relates to polypeptides (also referred to herein as CXCR4 binding molecules or polypeptides) that are directed against the G-coupled protein receptor CXCR4, also known as Fusin or CD184. The invention also relates to nucleic acids encoding such polypeptides; to methods for preparing such polypeptide; to compositions, and in particular to pharmaceutical compositions that comprise such polypeptides and to uses of such polypeptides for therapeutic or diagnostic purposes.

Abstract: The invention concerns a process for the manufacture of an acylated polymer composition comprising amylose and/or amylopectin, comprising a pre-treatment step in the presence of an acid, a salt and a polycarboxylic acid, subsequent acylation and, preferably, a post-treatment step with an acid. The products obtained are useful as additives in inks, varnishes, lacquers, coatings, thickeners, adhesives or binders.

Abstract: The present invention provides phosphonium-crosslinked chitosan (PCC) and methods for using the same for removal of heavy metal-ion(s) from a solution as well as methods for producing said phosphonium-crosslinked chitosan.

Abstract: The present invention relates to a modified polymer having a high modification ratio and an excellent affinity with a filler, a method of preparing the same, a rubber composition including the modified polymer, and a molded article prepared from the rubber composition. The modified polymer according to the present invention may exhibit a high modification ratio by including functional groups in a polymer main chain and on at least one end thereof, and thus, an affinity with a filler, such as silica, may be excellent. Also, the rubber composition according to the present invention may have excellent processability by including the modified polymer having an excellent affinity with the filler, and, as a result, a processed product (e.g., tire) prepared by using the rubber composition may have excellent tensile strength, abrasion resistance, and wet road surface resistance.

Abstract: A rubber composition including guayule rubber and 15 to 90 phr silica. The rubber can be cis-1,4 polyisoprene and include 15 to 90 phr silica and contain less than 20% of the proteins associated with Hevea rubber and further include at least a trace of resins present in other natural rubbers. The rubber can be cis-1,4 polyisoprene and further include between at least a trace and 3% by weight of resins present in guayule rubber. The rubber composition can further be comprised of a synthetic rubber and include between about 40-100 phr of guayule rubber, and silica. The silica can be hydrophobated.

Abstract: The present invention provides an azasilane-based modifier of Formula 1, which may easily introduce a functional group having affinity with a filler into a conjugated diene-based polymer chain, a modified and conjugated diene-based polymer including the functional group derived from the azasilane-based modifier, a method for preparing the modified and conjugated diene-based polymer, a rubber composition including the modified and conjugated diene-based polymer, and a molded article and a tire manufactured from the rubber composition.

Abstract: A method of forming a coating on a food or beverage container, which includes spraying a coating composition onto an interior surface of the food or beverage container, where the coating composition includes an emulsion-polymerized latex copolymer having copolymer chains of one or more ethylenically-unsaturated monomers and one or more styrene offset monomers. Preferably, the coating composition is substantially free of BPA, PVC, and styrene. The method may also include curing the sprayed coating composition, thereby providing the coating on the interior surface of the food or beverage container.

Abstract: The present invention relates to a novel ligand compound represented by Formula 1 and a novel transition metal compound represented by Formula 2, and the novel ligand compound and transition metal compound according to the present invention has high comonomer incorporation effect in the preparation of an olefinic polymer having a low density and a high molecular weight, and thus can be usefully used as a catalyst for a polymerization reaction.

Abstract: Catalyst systems and methods for making and using the same are disclosed. A catalyst composition is provided that includes a catalyst compound supported to form a supported catalyst system, the catalyst compound including: where each of R1, R2, R3, R4, R5, R6, R7 and X are as discussed herein.

Abstract: A method for producing low molecular weight polytetrafluoroethylene less likely to generate C8-C14 perfluorocarboxylic acids and salts thereof. The method includes: (1) feeding into an airtight container: polytetrafluoroethylene; at least one additive selected from the group consisting of hydrocarbons, chlorinated hydrocarbons, alcohols, and carboxylic acids other than C8-C14 perfluorocarboxylic acids; and at least one selected from the group consisting of inert gases other than the above additive and oxygen adsorbents; and (2) irradiating the polytetrafluoroethylene to provide low molecular weight polytetrafluoroethylene having a complex viscosity of 1×102 to 7×105 Pa·s at 380° C.

Abstract: This invention relates to a dicyclopentadiene (DCPD)-based resin functionalized with groups capable of reacting with silica or carbon black for use in high performance tires and a preferred method of preparing the functionalized resin comprising ruthenium-catalyzed ring-opening cross metathesis. The functionalized resin may comprise the reaction product obtained by contacting a polymer comprising units derived from (DCPD) and a vinyl monomer or vinylene monomer in the presence of a metathesis catalyst, wherein the vinyl monomer or vinylene monomer comprises at least one of the following functional groups: a silyl group, a siloxy group, or an alkoxysilyl group. This invention further relates to a tire tread composition comprising the functionalized resin and which exhibits enhanced durability, traction, handling, and extractability properties.

Abstract: The present invention provides a catalyst composition including a functionalizing agent of the following Formula 1 together with a rare earth metal compound, an alkylating agent, and a halogen compound, having good catalytic activity and polymerization reactivity and useful for the preparation of a conjugated diene-based polymer having high linearity and excellent processability, and a conjugated diene-based polymer prepared using the catalyst composition. (X1)a-M1-([Y-M2-(X2)n-1])m-a??[Formula 1] In Formula 1, a, m, n, M1, M2, X1, X2 and Y are the same as defined in the disclosure.

Abstract: The present invention provides a catalyst composition including a functionalizing agent of the following Formula 1 together with a rare earth metal compound, an alkylating agent, and a halogen compound, having good catalytic activity and polymerization reactivity and useful for the preparation of a conjugated diene-based polymer having high linearity and excellent processability, and a conjugated diene-based polymer prepared using the catalyst composition. (X1)a—Sn—(X2)4-a??[Formula 1] In Formula 1, a, X1, and X2 are the same as defined in the disclosure.

Abstract: A synthetic polyisoprene latex emulsion has pre-vulcanization composition and post vulcanization composition. The pre-vulcanization composition comprises soluble sulfur with high S8 ring structure that is catalytically broken by a zinc dithiocarbamate. Surfactants present in the pre-vulcanization composition wets synthetic polyisoprene particles and permeates small sized sulfur and accelerator molecules into the interior of these particles thereby pre-vulcanizing the particles. The degree of pre-vulcanization is verified by isopropanol index test. The latex emulsion has post-vulcanization composition with accelerators that crosslink inter-particle region during post vulcanization cure cycle. The dipped synthetic polyisoprene article is substantially uniformly cured both in the inter-particle and intra-particle regions and reliably exhibits high cross link density, uniform distribution of double bonds in TEM and zinc segregation at the boundaries or original particles by electron microprobe analysis.

Abstract: A thermosetting resin composition using a transesterification reaction as a curing reaction, which has a good curability and can be used in various applications. A thermosetting resin composition comprising a polymer (A) composed of a monomer having a (meth) acrylic acid tertiary alkyl ester and a monomer having a hydroxyl group as a structural unit, and a transesterification catalyst (B) as an essential component, and being organic solvent-type or water-borne, wherein the polymer (A) has a glass transition temperature of 80° C. or lower.

Abstract: Provided is a graft copolymer (A) obtainable by graft-polymerizing, in the presence of 30 to 80 parts by mass of an ethylene-based polymer (a), an aromatic vinyl-based monomer (b) and, if necessary, another vinyl-based monomer (c) copolymerizable with the aromatic vinyl-based monomer (b) in a total amount of 20 to 70 parts by mass (provided that the sum of the components (a), (b) and (c) is 100 parts by mass), in which the ethylene-based polymer (a) has a density of 0.900 g/cm3 or more and less than 0.966 g/cm3, a number average molecular weight of 10,000 to 50,000, and a molecular weight distribution of 5 to 15, and the proportion of the ethylene-based polymer (a) molecules having a molecular weight of 10,000 or less is 5.5% or more.

Abstract: A moisture-curable silylated resin is derived from a copolycarbonate diol prepared from diol(s) of specific types.

Abstract: The invention relates to an aqueously dispersible polyurethane having a specific amount of substance of hydroxyl groups, —OH, of at least 0.6 mol/kg, and additionally satisfying at least two of the following conditions: a) a degree of branching measured as specific amount of substance of tertiary and/or quaternary aliphatic carbon atoms of from 0.01 mol/kg to 0.5 mol/kg, b) a specific amount of urea groups >N—CO—N< of from 0.8 mol/kg to 2 mol/kg, and c) a specific amount of substance of hydroxyl groups, —OH, of from 1 mol/kg to 4 mol/kg, wherein in each case the specific amount of substance is based on the mass of the polyurethane, a process for the preparation thereof, and a method of use thereof.

Abstract: The purpose of the present invention is to provide a composition for forming a semi-rigid polyurethane foam that has low hardness and a resilient feel, has excellent moldability and curability even when made lightweight (made thin), and is suitable for use as an automobile interior material. The present invention is a composition for forming a semi-rigid polyurethane foam that comprises: a polyol mixture (P) that contains a specific polyol (the composition) (A), a water-containing foaming agent (C), and a catalyst (D); and a polyisocyanate component (B). The content of foaming agent (C) is 1.5-2.5 wt % based on the total weight of (A).

Abstract: A fiber-reinforced rigid polyurethane foam composite railway sleeper with high fiber content and a manufacturing method thereof. The railway sleeper is formed by bonding a plurality of fiber-reinforced rigid polyurethane foam composite boards with high fiber content by a binder, and the outer surface of the railway sleeper is provided with an anticorrosive paint film. The fiber-reinforced rigid polyurethane foam composite boards with high fiber content include a polyurethane resin as a matrix material and a fiber as a reinforcing material. The problem of insufficient impregnation of the polyurethane and the fiber is solved by using a plurality of technical means such as using a mixed polyether polyol having a low hydroxyl value and a low functionality, using a coupling agent, etc., thus a fiber-reinforced rigid polyurethane foam composite product having a density higher than 840 kg/m3 and a fiber content greater than 60% is manufactured.

Abstract: This invention relates to a thermally expandable fire-resistant resin composition comprising a resin component in an amount of 100 parts by weight, thermally expandable graphite in an amount of 3 to 300 parts by weight, and an inorganic filler in an amount of 2 to 200 parts by weight, wherein the thermally expandable graphite has an average aspect ratio of 20 or more.

Abstract: Fatty acid polyester derivatives of polyglycosides formed from a polyol having between 2 and 10 hydroxy functions, the 2 hydroxy functions or at least 2 of these hydroxy functions being bound to the anomeric carbon of a reducing carbohydrate that is identical or different for each hydroxy group and selected from the monosaccharides and disaccharides, in which at least one of the other hydroxy groups of the monosaccharide or the disaccharide is esterified by a lipid derivative bearing at least one double bond optionally originating from a vegetable or animal oil, from a mixture of vegetable or animal oils, the double bond or the at least one of the double bonds of the lipid derivative being functionalized by a group selected from the epoxy, amine, alcohol and acid groups, and use thereof in particular in reaction formulations for the production of polymer materials.

Abstract: Disclosed herein are redox-active 6-oxoverdazyl polymers having structures (S1) and (S2) synthesized via ring-opening metathesis polymerization (ROMP) and their solution, bulk, and thin-film properties investigated. Detailed studies of the ROMP method employed confirmed that stable radical polymers with controlled molecular weights and narrow molecular weight distributions (Ð<1.2) were produced. Thermal gravimetric analysis of a representative example of the title polymers demonstrated stability up to 190° C., while differential scanning calorimetry studies revealed a glass transition temperature of 152° C. An ultrathin memristor device was produced using these polymers, namely a 10 nm homogeneous thin film of poly-[1,5-diisopropyl-3-(cis-5-norbornene-exo-2,3-dicarboxiimide)-6-oxoverdazyl] (P6OV), a poly-radical with three tunable charge states per each radical monomer: positive, neutral and negative.

Abstract: A hydrogenated norbornene-based ring-opening polymer having a syndiotacticity ((racemo diads)/(meso diads+racemo diads)×100) of more than 90% is disclosed. A method for producing the same is also disclosed. It is thus possible to provide a hydrogenated highly syndiotactic norbornene-based ring-opening polymer that is formed of a single material, and exhibits high solvent resistance, and a method for producing the same.

Abstract: The present invention provides a method for preparing a polycarbonate by removing a solvent from a polycarbonate polymerization solution without impairing the physical properties of the polycarbonate.

Abstract: To provide a fluorinated ether compound, a fluorinated ether composition and a coating liquid, capable of forming a surface layer excellent in water/oil repellency, abrasion resistance, fingerprint stain removability, lubricity, chemical resistance and light resistance, as well as an article having such a surface layer. A fluorinated ether compound represented by A1-O-Q1-(Rf11O)m1—Rf12—R11—N[—R12—SiR13n1X13-n1]2, wherein A1: C1-20 perfluoroalkyl group, Q1: single bond, fluoroalkylene group containing at least one hydrogen atom, etc., Rf11, Rf12: perfluoroalkylene group, m1: integer of from 2 to 200, R11: single bond, alkylene group, etc., R12: alkylene group, etc., R13: monovalent hydrocarbon group, etc., X1: hydrolyzable group, n1: integer of from 0 to 2.

Abstract: Polyaryletherketones are produced which are end-capped with a phenylethynyl-containing moiety.

Abstract: Compositions including polyaspartic acid and methods for preparing polyaspartic acid using a precondensate of aspartic acid and polyaspartimide are provided herein. Uses for such compositions are also described.